Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Abdominal Radiology
Erschienen in: Abdominal Radiology 4/2020

01.04.2020 | Review

Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management

verfasst von: Ayahallah A. Ahmed, Aaron J. Thomas, Dhakshina Moorthy Ganeshan, Katherine J. Blair, Chandana Lall, James T. Lee, Ali I. Morshid, Mouhammed A. Habra, Khaled M. Elsayes

Erschienen in: Abdominal Radiology | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Adrenocortical carcinoma (ACC) is a rare tumor with a poor prognosis. Most tumors are either metastatic or locally invasive at the time of diagnosis. Differentiation between ACC and other adrenal masses depends on clinical, biochemical, and imaging factors. This review will discuss the genetics, pathological, and imaging feature of ACC.
Literatur
1.
Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, et al. Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. The Journal of clinical endocrinology and metabolism. 2006;91(7):2650-5.PubMed
2.
Wandoloski M, Bussey KJ, Demeure MJ. Adrenocortical cancer. The Surgical clinics of North America. 2009;89(5):1255-67.PubMed
3.
Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. The Journal of clinical endocrinology and metabolism. 2000;85(2):637-64.
4.
Else T. Association of adrenocortical carcinoma with familial cancer susceptibility syndromes. Molecular and cellular endocrinology. 2012;351(1):66-70.PubMed
5.
Libé R. Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment. Front Cell Dev Biol. 2015;3(45).
6.
Bharwani N, Rockall AG, Sahdev A, Gueorguiev M, Drake W, Grossman AB, et al. Adrenocortical carcinoma: the range of appearances on CT and MRI. AJR American journal of roentgenology. 2011;196(6):W706-14.PubMed
7.
Sharma E, Dahal S, Sharma P, Bhandari A, Gupta V, Amgai B, et al. The Characteristics and Trends in Adrenocortical Carcinoma: A United States Population Based Study. Journal of clinical medicine research. 2018;10(8):636-40.PubMedPubMedCentral
8.
Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World journal of surgery. 2006;30(5):872-8.PubMed
9.
Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, et al. Adrenocortical carcinoma. Endocrine reviews. 2014;35(2):282-326.PubMed
10.
Fassnacht M, Dekkers O, Else T, Baudin E, Berruti A, de Krijger RR, et al. European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors. European journal of endocrinology. 2018.
11.
Benassai G, Desiato V, Benassai G, Bianco T, Sivero L, Compagna R, et al. Adrenocortical carcinoma: what the surgeon needs to know. Case report and literature review. International journal of surgery (London, England). 2014;12 Suppl 1:S22-8.
12.
Zini L, Porpiglia F, Fassnacht M. Contemporary management of adrenocortical carcinoma. European urology. 2011;60(5):1055-65.PubMed
13.
Adkins KM, Lee JT, Bress AL, Spires SE, Lee CY, Ayoob AR. Classic Cushing’s syndrome in a patient with adrenocortical carcinoma. Radiology case reports. 2013;8(3):826.PubMed
14.
Allolio B, Fassnacht M. Clinical review: Adrenocortical carcinoma: clinical update. The Journal of clinical endocrinology and metabolism. 2006;91(6):2027-37.PubMed
15.
Lau SK, Weiss LM. The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Human pathology. 2009;40(6):757-68.PubMed
16.
Papotti M, Libe R, Duregon E, Volante M, Bertherat J, Tissier F. The Weiss score and beyond–histopathology for adrenocortical carcinoma. Hormones & cancer. 2011;2(6):333-40.
17.
Erickson LA. Challenges in surgical pathology of adrenocortical tumours. Histopathology. 2018;72(1):82-96.PubMed
18.
Vatrano S, Volante M, Duregon E, Giorcelli J, Izzo S, Rapa I, et al. Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2018;31(8):1257-69.
19.
Angelousi A, Zilbermint M, Berthon A, Espiard S, Stratakis CA. Diagnosis and Management of Hereditary Adrenal Cancer. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer. 2016;205:125-47.PubMed
20.
Griniatsos JE, Dimitriou N, Zilos A, Sakellariou S, Evangelou K, Kamakari S, et al. Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene. World journal of surgical oncology. 2011;9:6.PubMedPubMedCentral
21.
Gaujoux S, Pinson S, Gimenez-Roqueplo AP, Amar L, Ragazzon B, Launay P, et al. Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010;16(21):5133-41.
22.
Kratz CP, Achatz MI, Brugieres L, Frebourg T, Garber JE, Greer MC, et al. Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017;23(11):e38-e45.
23.
Challis BG, Kandasamy N, Powlson AS, Koulouri O, Annamalai AK, Happerfield L, et al. Familial Adrenocortical Carcinoma in Association With Lynch Syndrome. The Journal of clinical endocrinology and metabolism. 2016;101(6):2269-72.PubMedPubMedCentral
24.
Marlon A. Guerrero EK. Adrenocortical Carcinoma and Synchronous Malignancies. Journal of Cancer. 2010;1(1):108-11.
25.
Creemers SG, Hofland LJ, Korpershoek E, Franssen GJ, van Kemenade FJ, de Herder WW, et al. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma. Endocrine-related cancer. 2016;23(1):R43-69.PubMed
26.
Soon PSH, McDonald KL, Robinson BG, Sidhu SB. Molecular Markers and the Pathogenesis of Adrenocortical Cancer. Oncologist. 2008;13(5):548-61.PubMed
27.
Almeida MQ, Fragoso MC, Lotfi CF, Santos MG, Nishi MY, Costa MH, et al. Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. The Journal of clinical endocrinology and metabolism. 2008;93(9):3524-31.PubMed
28.
Rubin B, Regazzo D, Redaelli M, Mucignat C, Citton M, Iacobone M, et al. Investigation of N-cadherin/beta-catenin expression in adrenocortical tumors. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016;37(10):13545-55.
29.
Phan LM, Fuentes-Mattei E, Wu W, Velazquez-Torres G, Sircar K, Wood CG, et al. Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma. Cancer research. 2015;75(19):4131-42.PubMedPubMedCentral
30.
Ayala-Ramirez M, Jasim S, Feng L, Ejaz S, Deniz F, Busaidy N, et al. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. European journal of endocrinology. 2013;169(6):891-9.PubMedPubMedCentral
31.
Sharma KV, Venkatesan AM, Swerdlow D, DaSilva D, Beck A, Jain N, et al. Image-guided adrenal and renal biopsy. Techniques in vascular and interventional radiology. 2010;13(2):100-9.PubMedPubMedCentral
32.
Trojan J, Schwarz W, Sarrazin C, Thalhammer A, Vogl TJ, Dietrich CF. Role of ultrasonography in the detection of small adrenal masses. Ultraschall in der Medizin (Stuttgart, Germany : 1980). 2002;23(2):96-100.
33.
Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. The Journal of urology. 2003;169(1):5-11.PubMed
34.
Hamper UM, Fishman EK, Hartman DS, Roberts JL, Sanders RC. Primary adrenocortical carcinoma: sonographic evaluation with clinical and pathologic correlation in 26 patients. AJR American journal of roentgenology. 1987;148(5):915-9.PubMed
35.
Lattin GE, Jr., Sturgill ED, Tujo CA, Marko J, Sanchez-Maldonado KW, Craig WD, et al. From the radiologic pathology archives: Adrenal tumors and tumor-like conditions in the adult: radiologic-pathologic correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 2014;34(3):805-29.
36.
Albano D, Agnello F, Midiri F, Pecoraro G, Bruno A, Alongi P, et al. Imaging features of adrenal masses. Insights into imaging. 2019;10(1):1.PubMedPubMedCentral
37.
Fulmer B. Diagnosis and management of adrenal cortical carcinoma. Current Urology Reports. 2007;8(1):77-82.PubMed
38.
Iniguez-Ariza NM, Kohlenberg JD, Delivanis DA, Hartman RP, Dean DS, Thomas MA, et al. Clinical, Biochemical, and Radiological Characteristics of a Single-Center Retrospective Cohort of 705 Large Adrenal Tumors. Mayo Clinic proceedings Innovations, quality & outcomes. 2018;2(1):30-9.
39.
Shin YR, Kim KA. Imaging Features of Various Adrenal Neoplastic Lesions on Radiologic and Nuclear Medicine Imaging. AJR American journal of roentgenology. 2015;205(3):554-63.PubMed
40.
Johnson PT, Horton KM, Fishman EK. Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics : a review publication of the Radiological Society of North America, Inc. 2009;29(5):1333-51.
41.
Zhang HM, Perrier ND, Grubbs EG, Sircar K, Ye ZX, Lee JE, et al. CT features and quantification of the characteristics of adrenocortical carcinomas on unenhanced and contrast-enhanced studies. Clinical radiology. 2012;67(1):38-46.PubMed
42.
Rowe SP, Lugo-Fagundo C, Ahn H, Fishman EK, Prescott JD. What the radiologist needs to know: the role of preoperative computed tomography in selection of operative approach for adrenalectomy and review of operative techniques. Abdominal radiology (New York). 2019;44(1):140-53.
43.
Gaujoux S, Mihai R. European Society of Endocrine Surgeons (ESES) and European Network for the Study of Adrenal Tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma. The British journal of surgery. 2017;104(4):358-76.PubMed
44.
Blake MAC, Carmel G;Boland, Giles W. Adrenal Imaging. AJR American journal of roentgenology. 2010;194.6:1450–60.
45.
Jiang M, Ding H, Li C, Xiang K, Tang J, Guo Y, et al. Surgical resection of adrenocortical carcinoma with invasion into the inferior vena cava: a case report and literature review. Clin Case Rep. 2017;5(12):1934-7.PubMedPubMedCentral
46.
Elbanna KY, Khalili K, O’Malley M, Chawla T. Imaging and implications of tumor thrombus in abdominal malignancies: reviewing the basics. Abdominal radiology (New York). 2019.
47.
Hricak H, Amparo E, Fisher MR, Crooks L, Higgins CB. Abdominal venous system: assessment using MR. Radiology. 1985;156(2):415-22.PubMed
48.
Tucci S, Jr., Martins AC, Suaid HJ, Cologna AJ, Reis RB. The impact of tumor stage on prognosis in children with adrenocortical carcinoma. The Journal of urology. 2005;174(6):2338-42, discussion 42.
49.
Sandrasegaran K, Patel AA, Ramaswamy R, Samuel VP, Northcutt BG, Frank MS, et al. Characterization of adrenal masses with diffusion-weighted imaging. AJR American journal of roentgenology. 2011;197(1):132-8.PubMed
50.
Martin Noguerol T, Sanchez-Gonzalez J, Martinez Barbero JP, Garcia-Figueiras R, Baleato-Gonzalez S, Luna A. Clinical Imaging of Tumor Metabolism with (1)H Magnetic Resonance Spectroscopy. Magnetic resonance imaging clinics of North America. 2016;24(1):57-86.PubMed
51.
Melo HJ, Goldman SM, Szejnfeld J, Faria JF, Huayllas MK, Andreoni C, et al. Application of a protocol for magnetic resonance spectroscopy of adrenal glands: an experiment with over 100 cases. Radiologia brasileira. 2014;47(6):333-41.PubMedPubMedCentral
52.
Imperiale A, Elbayed K, Moussallieh FM, Reix N, Piotto M, Bellocq JP, et al. Metabolomic profile of the adrenal gland: from physiology to pathological conditions. Endocrine-related cancer. 2013;20(5):705-16.PubMed
53.
Faria JF, Goldman SM, Szejnfeld J, Melo H, Kater C, Kenney P, et al. Adrenal masses: characterization with in vivo proton MR spectroscopy–initial experience. Radiology. 2007;245(3):788-97.PubMed
54.
Guerin C, Pattou F, Brunaud L, Lifante JC, Mirallie E, Haissaguerre M, et al. Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study. The Journal of clinical endocrinology and metabolism. 2017;102(7):2465-72.PubMed
55.
Groussin L, Bonardel G, Silvera S, Tissier F, Coste J, Abiven G, et al. 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. The Journal of clinical endocrinology and metabolism. 2009;94(5):1713-22.PubMed
56.
Kim SJ, Lee SW, Pak K, Kim IJ, Kim K. Diagnostic accuracy of (18)F-FDG PET or PET/CT for the characterization of adrenal masses: a systematic review and meta-analysis. The British journal of radiology. 2018;91(1086):20170520.PubMedPubMedCentral
57.
Blake MA, Slattery JM, Kalra MK, Halpern EF, Fischman AJ, Mueller PR, et al. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy–initial experience. Radiology. 2006;238(3):970-7.PubMed
58.
Cistaro A, Niccoli Asabella A, Coppolino P, Quartuccio N, Altini C, Cucinotta M, et al. Diagnostic accuracy of (18)F-FDG PET or PET/CT for the characterization of adrenal masses: a systematic review and meta-analysis Hellenic journal of nuclear medicine. 2015;18(2):97-102.
59.
Mayo-Smith WW, Song JH, Boland GL, Francis IR, Israel GM, Mazzaglia PJ, et al. Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee. Journal of the American College of Radiology : JACR. 2017;14(8):1038-44.PubMed
60.
Fassnacht M, Allolio B. What is the best approach to an apparently nonmetastatic adrenocortical carcinoma? Clinical endocrinology. 2010;73(5):561-5.PubMed
61.
Mackie GC, Shulkin BL, Ribeiro RC, Worden FP, Gauger PG, Mody RJ, et al. Use of [18F]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. The Journal of clinical endocrinology and metabolism. 2006;91(7):2665-71.PubMed
62.
Tessonnier L, Ansquer C, Bournaud C, Sebag F, Mirallie E, Lifante JC, et al. (18)F-FDG uptake at initial staging of the adrenocortical cancers: a diagnostic tool but not of prognostic value. World journal of surgery. 2013;37(1):107-12.PubMed
63.
Takeuchi S, Balachandran A, Habra MA, Phan AT, Bassett RL, Jr., Macapinlac HA, et al. Impact of (1)(8)F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients. European journal of nuclear medicine and molecular imaging. 2014;41(11):2066-73.PubMed
64.
Hahner S, Sundin A. Metomidate-based imaging of adrenal masses. Hormones & cancer. 2011;2(6):348-53.
65.
Mendichovszky IA, Powlson AS, Manavaki R, Aigbirhio FI, Cheow H, Buscombe JR, et al. Targeted Molecular Imaging in Adrenal Disease-An Emerging Role for Metomidate PET-CT. Diagnostics (Basel, Switzerland). 2016;6(4).
66.
Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2016;278(2):563-77.PubMed
67.
Yip SSF, Aerts HJWL. Applications and limitations of radiomics. Physics in Medicine and Biology. 2016;61(13):R150-66.PubMedPubMedCentral
68.
Romeo V, Maurea S, Cuocolo R, Petretta M, Mainenti PP, Verde F, et al. Characterization of Adrenal Lesions on Unenhanced MRI Using Texture Analysis: A Machine-Learning Approach. Journal of magnetic resonance imaging : JMRI. 2018;48(1):198-204.PubMed
69.
Ho LM, Samei E, Mazurowski MA, Zheng Y, Allen BC, Nelson RC, et al. Can Texture Analysis Be Used to Distinguish Benign From Malignant Adrenal Nodules on Unenhanced CT, Contrast-Enhanced CT, or In-Phase and Opposed-Phase MRI? AJR American journal of roentgenology. 2019;212(3):554-61.PubMed
70.
Elmohr MM, Fuentes D, Habra MA, Bhosale PR, Qayyum AA, Gates E, et al. Machine learning-based texture analysis for differentiation of large adrenal cortical tumours on CT. Clin Radiol. 2019;74(10):818.e1-.e7.
71.
Kerkhofs TM, Verhoeven RH, Van der Zwan JM, Dieleman J, Kerstens MN, Links TP, et al. Adrenocortical carcinoma: a population-based study on incidence and survival in the Netherlands since 1993. European journal of cancer (Oxford, England : 1990). 2013;49(11):2579-86.
72.
Fassnacht M, Johanssen S, Quinkler M, Bucsky P, Willenberg HS, Beuschlein F, et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer. 2009;115(2):243-50.PubMed
73.
Poorman CE, Ethun CG, Postlewait LM, Tran TB, Prescott JD, Pawlik TM, et al. A Novel T-Stage Classification System for Adrenocortical Carcinoma: Proposal from the US Adrenocortical Carcinoma Study Group. Annals of surgical oncology. 2018;25(2):520-7.PubMed
74.
Reginelli A, Di Grezia G, Izzo A, D’Andrea A, Gatta G, Cappabianca S, et al. Imaging of adrenal incidentaloma: our experience. International journal of surgery (London, England). 2014;12 Suppl 1:S126-31.
75.
Vaidya A, Hamrahian A, Bancos I, Fleseriu M, Ghayee HK. THE EVALUATION OF INCIDENTALLY DISCOVERED ADRENAL MASSES. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2019;25(2):178-92.
76.
Kapoor A, Morris T, Rebello R. Guidelines for the management of the incidentally discovered adrenal mass. Canadian Urological Association journal = Journal de l’Association des urologues du Canada. 2011;5(4):241-7.
77.
Sahdev A, Willatt J, Francis IR, Reznek RH. The indeterminate adrenal lesion. Cancer imaging : the official publication of the International Cancer Imaging Society. 2010;10:102-13.
78.
Adam SZ, Nikolaidis P, Horowitz JM, Gabriel H, Hammond NA, Patel T, et al. Chemical Shift MR Imaging of the Adrenal Gland: Principles, Pitfalls, and Applications. Radiographics : a review publication of the Radiological Society of North America, Inc. 2016;36(2):414-32.
79.
Sahdev A. Recommendations for the management of adrenal incidentalomas: what is pertinent for radiologists? The British journal of radiology. 2017;90(1072):20160627.PubMedPubMedCentral
80.
Egbert N, Elsayes KM, Azar S, Caoili EM. Computed tomography of adrenocortical carcinoma containing macroscopic fat. Cancer imaging : the official publication of the International Cancer Imaging Society. 2010;10(1):198-200.
81.
Katabathina VS, Flaherty E, Kaza R, Ojili V, Chintapalli KN, Prasad SR. Adrenal collision tumors and their mimics: multimodality imaging findings. Cancer imaging : the official publication of the International Cancer Imaging Society. 2013;13(4):602-10.
82.
Saeger W, Fassnacht M, Chita R, Prager G, Nies C, Lorenz K, et al. High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Human pathology. 2003;34(2):180-6.PubMed
83.
Villelli NW, Jayanti MK, Zynger DL. Use and usefulness of adrenal core biopsies without FNA or on-site evaluation of adequacy: a study of 204 cases for a 12-year period. American journal of clinical pathology. 2012;137(1):124-31.PubMed
84.
Phan AT. Adrenal cortical carcinoma–review of current knowledge and treatment practices. Hematology/oncology clinics of North America. 2007;21(3):489-507; viii-ix.
85.
Bancos I, Tamhane S, Shah M, Delivanis DA, Alahdab F, Arlt W, et al. DIAGNOSIS OF ENDOCRINE DISEASE: The diagnostic performance of adrenal biopsy: a systematic review and meta-analysis. European journal of endocrinology. 2016;175(2):R65-80.PubMed
86.
Wahab NA, Mohd R, Zainudin S, Kamaruddin NA. Adrenal involvement in histoplasmosis. EXCLI journal. 2013;12:1-4.PubMed
87.
Williams AR, Hammer GD, Else T. Transcutaneous biopsy of adrenocortical carcinoma is rarely helpful in diagnosis, potentially harmful, but does not affect patient outcome. European journal of endocrinology. 2014;170(6):829-35.PubMedPubMedCentral
88.
Blake MA, Kalra MK, Maher MM, Sahani DV, Sweeney AT, Mueller PR, et al. Pheochromocytoma: an imaging chameleon. Radiographics : a review publication of the Radiological Society of North America, Inc. 2004;24 Suppl 1:S87-99.
89.
Wang F, Liu J, Zhang R, Bai Y, Li C, Li B, et al. CT and MRI of adrenal gland pathologies. Quantitative imaging in medicine and surgery. 2018;8(8):853-75.PubMedPubMedCentral
90.
Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. The Journal of clinical endocrinology and metabolism. 2014;99(6):1915-42.PubMed
91.
Elsayes KM, Mukundan G, Narra VR, Lewis JS, Jr., Shirkhoda A, Farooki A, et al. Adrenal masses: mr imaging features with pathologic correlation. Radiographics : a review publication of the Radiological Society of North America, Inc. 2004;24 Suppl 1:S73-86.
92.
Li B, Guo Q, Yang H, Guan J. Giant non-functional adrenal adenoma: A case report. Oncology letters. 2013;5(1):378-80.PubMed
93.
Newhouse JH, Heffess CS, Wagner BJ, Imray TJ, Adair CF, Davidson AJ. Large degenerated adrenal adenomas: radiologic-pathologic correlation. Radiology. 1999;210(2):385-91.PubMed
94.
Herr K, Muglia VF, Koff WJ, Westphalen AC. Imaging of the adrenal gland lesions. Radiologia brasileira. 2014;47:228-39.PubMedPubMedCentral
95.
Uberoi J, Munver R. Surgical management of metastases to the adrenal gland: Open, laparoscopic, and ablative approaches. Current Urology Reports. 2009;10(1):67.PubMed
96.
Alshahrani MA, Bin Saeedan M, Alkhunaizan T, Aljohani IM, Azzumeea FM. Bilateral adrenal abnormalities: imaging review of different entities. Abdominal radiology (New York). 2019;44(1):154-79.
97.
Joseph FG, Cook S, Gowda D. Primary adrenal lymphoma with initial presentation concerning for bilateral adrenal pheochromocytomas. BMJ case reports. 2017;2017:bcr-2017-220549.
98.
Toogood V, Milliken S, Morey A, Samaras K. Adrenal tumours: How to establish malignancy. BMJ case reports. 2014;2014:bcr2014203736.
99.
Guo YK, Yang ZG, Li Y, Deng YP, Ma ES, Min PQ, et al. Uncommon adrenal masses: CT and MRI features with histopathologic correlation. European journal of radiology. 2007;62(3):359-70.PubMed
100.
Majbar AM, Elmouhadi S, Elaloui M, Raiss M, Sabbah F, Hrora A, et al. Imaging features of adrenal ganglioneuroma: a case report. BMC research notes. 2014;7:791.PubMedPubMedCentral
101.
Shawa H, Elsayes KM, Javadi S, Morani A, Williams MD, Lee JE, et al. Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centre. Clinical endocrinology. 2014;80(3):342-7.PubMed
102.
Linos D, Tsirlis T, Kapralou A, Kiriakopoulos A, Tsakayannis D, Papaioannou D. Adrenal ganglioneuromas: incidentalomas with misleading clinical and imaging features. Surgery. 2011;149(1):99-105.PubMed
103.
Heidari Z, Kaykhaei MA, Jahantigh M, Sheikhi V. Adrenal Ganglioneuroblastoma in an Adult: A Rare Case Report. International journal of endocrinology and metabolism. 2018;16(1):e63055.PubMedPubMedCentral
104.
Koike K, Iihara M, Kanbe M, Omi Y, Aiba M, Obara T. Adult-Type Ganglioneuroblastoma in the Adrenal Gland Treated by a Laparoscopic Resection: Report of a Case. Surgery Today. 2003;33(10):785-90.PubMed
105.
Taffel M, Haji-Momenian S, Nikolaidis P, Miller FH. Adrenal imaging: a comprehensive review. Radiologic clinics of North America. 2012;50(2):219-43, v.
106.
Eric Jordan LP, Jesse Courtier, Victor Sai, Adam Jung, Fergus V. Coakley Imaging of Nontraumatic Adrenal Hemorrhage. AJR American journal of roentgenology. 2012;199(1):W91-W8.
107.
Wang L-J, Wong Y-C, Chen C-J, Chu S-H. Imaging spectrum of adrenal pseudocysts on CT. European Radiology. 2003;13(3):531-5.PubMed
108.
Isono M, Ito K, Seguchi K, Kimura T, Tachi K, Kono T, et al. A Case of Hemorrhagic Adrenal Pseudocyst Mimicking Solid Tumor. The American journal of case reports. 2017;18:1034-8.PubMedPubMedCentral
109.
Feo CV, De Troia A, Pedriali M, Sala S, Zatelli MC, Carcoforo P, et al. Adrenal cavernous hemangioma: a case report. BMC surgery. 2018;18(1):103.PubMedPubMedCentral
110.
Zemni I, Haddad S, Hlali A, Manai MH, Essoussi M. Adrenal gland hemangioma: A rare case of the incidentaloma: Case report. International journal of surgery case reports. 2017;41:417-22.PubMedPubMedCentral
111.
Puglisi S, Perotti P, Cosentini D, Roca E, Basile V, Berruti A, et al. Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. Expert review of anticancer therapy. 2018;18(11):1125-33.PubMed
112.
Gaujoux S, Weinandt M, Bonnet S, Reslinger V, Bertherat J, Dousset B. Surgical treatment of adrenal carcinoma. Journal of visceral surgery. 2017;154(5):335-43.PubMed
113.
Annamaria P, Silvia P, Bernardo C, Alessandro de L, Antonino M, Antonio B, et al. Adrenocortical carcinoma with inferior vena cava, left renal vein and right atrium tumor thrombus extension. International journal of surgery case reports. 2015;15:137-9.PubMedPubMedCentral
114.
Paragliola RM, Torino F, Papi G, Locantore P, Pontecorvi A, Corsello SM. Role of Mitotane in Adrenocortical Carcinoma - Review and State of the art. European endocrinology. 2018;14(2):62-6.PubMedPubMedCentral
115.
Strosberg JR. Update on the management of unusual neuroendocrine tumors: pheochromocytoma and paraganglioma, medullary thyroid cancer and adrenocortical carcinoma. Seminars in oncology. 2013;40(1):120-33.PubMed
116.
Calabrese A, Basile V, Puglisi S, Perotti P, Pia A, Saba L, et al. Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. European journal of endocrinology. 2019;180(6):387-96.PubMed
117.
Berruti A, Baudin E, Gelderblom H, Haak HR, Porpiglia F, Fassnacht M, et al. Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology. 2012;23 Suppl 7:vii131-8.
Metadaten
Titel
Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management
verfasst von
Ayahallah A. Ahmed
Aaron J. Thomas
Dhakshina Moorthy Ganeshan
Katherine J. Blair
Chandana Lall
James T. Lee
Ali I. Morshid
Mouhammed A. Habra
Khaled M. Elsayes
Publikationsdatum
01.04.2020
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 4/2020
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02371-y

Weitere Artikel der Ausgabe 4/2020

Abdominal Radiology 4/2020 Zur Ausgabe

Letter to the Editor

Response to letter to the editor

Hepatobiliary

The added value of dual-time-point 18F-FDG PET/CT imaging in the diagnosis of colorectal cancer liver metastases

Review

Clinical impact of FDG PET/CT in alimentary tract malignancies: an updated review

Editorial

Introduction to the special issue on adrenal imaging

Special Section: Adrenal Gland

Mimics, pitfalls, and misdiagnoses of adrenal masses on CT and MRI

Review

Imaging findings of infectious and inflammatory diseases of the urinary system mimicking neoplastic diseases

Neu im Fachgebiet Radiologie

18.04.2024 | Pädiatrische Notfallmedizin | Nachrichten

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

13.04.2024 | Klinik aktuell | Kongressbericht | Nachrichten

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

08.04.2024 | Andrologie | Nachrichten

Wie toxische Männlichkeit der Gesundheit von Männern schadet

29.03.2024 | Diagnostische Radiologie | Nachrichten

Studie bestätigt Potenzial von KI in der Radiologie
weitere anzeigen

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen